Los Angeles, CA — Dec 2025.
SBMT is honored to welcome Dr. Denis Fedorenko—one of the world’s most influential figures in autologous hematopoietic stem cell transplantation (AHSCT)—as a Keynote Speaker at the 2026 World Brain Mapping & Therapeutics Annual Conference in Los Angeles.
For more than two decades, Dr. Fedorenko has advanced the understanding and treatment of complex hematologic and autoimmune disorders, with a specialized focus on multiple sclerosis and CNS autoimmune disease. His work has transformed clinical practice in Russia and influenced global standards of care.
Dr. Fedorenko began his medical career at the Kirov’s Medical Academy in St. Petersburg, later joining the prestigious A.A. Maximov Hematology and Cellular Therapy Department in Moscow, where he played a key role in establishing one of the most advanced transplantation programs in the region. His contributions have been recognized with European Hematology Association (EHA) awards in 2014 and 2016, highlighting his impact on hematology and oncology research.
He has authored 200+ scientific publications, holds multiple patents, and actively collaborates with leading international societies—including ASH, EHA, EBMT, and SBMT—pushing the boundaries of innovation in stem cell therapy, quality-of-life research, and transformative clinical protocols.
At SBMT 2026, Dr. Fedorenko will share breakthrough insights on the evolution, effectiveness, and future of autologous transplantation for MS and autoimmune disorders, exploring how these therapies reshape long-term neurological outcomes and expand the frontier of personalized medicine.
This keynote will be a landmark session for clinicians, researchers, and industry leaders seeking to understand the next decade of neuro-immunology and regenerative therapeutics.
🔥 Get ready for one of the most anticipated sessions of SBMT 2026.
More speaker announcements coming soon.
